These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
224 related items for PubMed ID: 9366314
1. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A. J Urol; 1997 Dec; 158(6):2069-73. PubMed ID: 9366314 [Abstract] [Full Text] [Related]
2. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest. Zerwekh JE, Odvina CV, Wuermser LA, Pak CY. J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313 [Abstract] [Full Text] [Related]
3. Citrate salts for preventing and treating calcium containing kidney stones in adults. Phillips R, Hanchanale VS, Myatt A, Somani B, Nabi G, Biyani CS. Cochrane Database Syst Rev; 2015 Oct 06; 2015(10):CD010057. PubMed ID: 26439475 [Abstract] [Full Text] [Related]
4. The effect of varying molar ratios of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss. Ruml LA, Wuermser LA, Poindexter J, Pak CY. J Clin Pharmacol; 1998 Nov 06; 38(11):1035-41. PubMed ID: 9824785 [Abstract] [Full Text] [Related]
6. Effect of potassium magnesium citrate on thiazide-induced hypokalemia and magnesium loss. Ruml LA, Pak CY. Am J Kidney Dis; 1999 Jul 06; 34(1):107-13. PubMed ID: 10401023 [Abstract] [Full Text] [Related]
7. Effect of varying doses of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss. Ruml LA, Gonzalez G, Taylor R, Wuermser LA, Pak CY. Am J Ther; 1999 Jan 06; 6(1):45-50. PubMed ID: 10423646 [Abstract] [Full Text] [Related]
8. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY. J Urol; 1993 Dec 06; 150(6):1761-4. PubMed ID: 8230497 [Abstract] [Full Text] [Related]
9. Citrate and renal calculi: new insights and future directions. Pak CY. Am J Kidney Dis; 1991 Apr 06; 17(4):420-5. PubMed ID: 2008910 [Abstract] [Full Text] [Related]
10. Bioavailability of potassium and magnesium, and citraturic response from potassium-magnesium citrate. Koenig K, Padalino P, Alexandrides G, Pak CY. J Urol; 1991 Feb 06; 145(2):330-4. PubMed ID: 1988724 [Abstract] [Full Text] [Related]
16. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy. Pak CY, Sakhaee K, Fuller CJ. Trans Assoc Am Physicians; 1983 Feb 06; 96():294-305. PubMed ID: 6679957 [Abstract] [Full Text] [Related]
17. Potassium-magnesium citrate versus potassium chloride in thiazide-induced hypokalemia. Wuermser LA, Reilly C, Poindexter JR, Sakhaee K, Pak CY. Kidney Int; 2000 Feb 06; 57(2):607-12. PubMed ID: 10652038 [Abstract] [Full Text] [Related]
18. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis. Preminger GM, Sakhaee K, Skurla C, Pak CY. J Urol; 1985 Jul 06; 134(1):20-3. PubMed ID: 4009822 [Abstract] [Full Text] [Related]
19. Long-term treatment of calcium nephrolithiasis with potassium citrate. Pak CY, Fuller C, Sakhaee K, Preminger GM, Britton F. J Urol; 1985 Jul 06; 134(1):11-9. PubMed ID: 3892044 [Abstract] [Full Text] [Related]